140 related articles for article (PubMed ID: 8853496)
21. Exercise and cancer: no pain, some gain?
Rayson D; Reyno L
J Clin Oncol; 2003 May; 21(9):1651-2. PubMed ID: 12721237
[No Abstract] [Full Text] [Related]
22. Re: E. David Crawford, Per-Anders Abrahamsson. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Eur Urol 2008;54:262-73.
Kvåle R; Hernes E; Bray F
Eur Urol; 2009 May; 55(5):e88-9; author reply e90-1. PubMed ID: 19062155
[No Abstract] [Full Text] [Related]
23. Improving the quality of life of patients with prostate carcinoma: a randomized trial testing the efficacy of a nurse-driven intervention.
Giesler RB; Given B; Given CW; Rawl S; Monahan P; Burns D; Azzouz F; Reuille KM; Weinrich S; Koch M; Champion V
Cancer; 2005 Aug; 104(4):752-62. PubMed ID: 15986401
[TBL] [Abstract][Full Text] [Related]
24. What is the best approach for screen-detected low volume cancers?--The case for observation.
Klotz L
Urol Oncol; 2008; 26(5):495-9. PubMed ID: 18774462
[TBL] [Abstract][Full Text] [Related]
25. Confidence in the ability to communicate with physicians among low-income patients with prostate cancer.
Maliski SL; Kwan L; Krupski T; Fink A; Orecklin JR; Litwin MS
Urology; 2004 Aug; 64(2):329-34. PubMed ID: 15302489
[TBL] [Abstract][Full Text] [Related]
26. Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?
Korfage IJ; de Koning HJ; Habbema JD; Schröder FH; Essink-Bot ML
BJU Int; 2007 Apr; 99(4):801-6. PubMed ID: 17233804
[TBL] [Abstract][Full Text] [Related]
27. Screening for prostate cancer: are we ready?
Adami HO; Baron J
Cancer Epidemiol Biomarkers Prev; 1994; 3(3):193-5. PubMed ID: 8019365
[No Abstract] [Full Text] [Related]
28. Open to debate. The motion: there is evidence that prostate cancer screening does more good than harm.
Schröder FH; Albertsen P
Eur Urol; 2006 Aug; 50(2):377-80. PubMed ID: 16762483
[No Abstract] [Full Text] [Related]
29. [Screening for cancer of the prostate: a life-saver or a waste of money?].
Rutishauser G; Graber P; Leisinger HJ; Schmid HP
Ann Urol (Paris); 1994; 28(4):176-7. PubMed ID: 7979206
[No Abstract] [Full Text] [Related]
30. Does the manner in which information about prostate-specific antigen (PSA) testing is presented affect screening rates?
Lockman AR
J Fam Pract; 2001 Oct; 50(10):898. PubMed ID: 11674897
[No Abstract] [Full Text] [Related]
31. Re: Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.
Schröder FH; Roobol MJ
BJU Int; 2009 Jan; 103(2):143-4. PubMed ID: 19076150
[No Abstract] [Full Text] [Related]
32. Quality of life assessment in prostatic cancer.
Da Silva FC; Aaronson N
Prog Clin Biol Res; 1988; 260():119-21. PubMed ID: 2966404
[No Abstract] [Full Text] [Related]
33. Screening for prostate cancer.
Postma R; Schröder FH
Eur J Cancer; 2005 Apr; 41(6):825-33. PubMed ID: 15808952
[TBL] [Abstract][Full Text] [Related]
34. Quality of life after treatment for prostate cancer: no difference between surgery and radiotherapy?
Vordermark D; Koelbl O
J Clin Oncol; 2003 Dec; 21(24):4655; author reply 4655-6. PubMed ID: 14673059
[No Abstract] [Full Text] [Related]
35. [Quality of life of patients with locally-advanced prostate cancer as a criterium of therapeutic effectiveness].
Kaprin AD; Kostin AA; Tsybul'skiĭ AD
Vopr Onkol; 2009; 55(3):285-90. PubMed ID: 19670727
[No Abstract] [Full Text] [Related]
36. Prostate cancer screening: more harm than good?
Lefevre ML
Am Fam Physician; 1998 Aug; 58(2):432-8. PubMed ID: 9713397
[TBL] [Abstract][Full Text] [Related]
37. Commentary on watchful waiting and health related quality of life for patients with localized prostate cancer.
Strope SA; Hollenbeck BK
J Urol; 2008 May; 179(5 Suppl):S19. PubMed ID: 18405741
[No Abstract] [Full Text] [Related]
38. Vitamin E in the prevention of prostate cancer: where are we today?
Lee IM; Gaziano JM; Buring JE
J Natl Cancer Inst; 2006 Feb; 98(4):225-7. PubMed ID: 16478736
[No Abstract] [Full Text] [Related]
39. What studies should be undertaken in Canada to determine the value of various treatment strategies for clinically localized prostate cancer?
Can J Oncol; 1994 Nov; 4 Suppl 1():124-7. PubMed ID: 8853504
[No Abstract] [Full Text] [Related]
40. [Mass screening for prostate cancer--how to eliminate clinically insignificant cancer].
Imai K; Kubota H
Gan To Kagaku Ryoho; 1998 May; 25(6):809-12. PubMed ID: 9617317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
